Resilience Invests in Pathogen-Killing MicroShield

Resilience Invests in Pathogen-Killing MicroShield

Resilience Capital Partners has formed a joint venture with MShield Holdings and its affiliate, MShield Healthcare (together MShield), to market MicroShield 360, an antimicrobial coating system. MicroShield 360 is EPA-registered and FDA-approved and is colorless, odorless, non-toxic and hypoallergenic and reduces microbial contamination of bacteria, viruses, mold, algae, yeast, mildew, fungi and other potentially disease-causing […]